Ignite Creation Date:
2025-12-24 @ 1:53 PM
Ignite Modification Date:
2026-01-27 @ 10:24 AM
Study NCT ID:
NCT01357395
Status:
COMPLETED
Last Update Posted:
2024-08-02
First Post:
2011-05-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 2, Open-Label Study of Amuvatinib in Combination With Platinum-Etoposide Chemotherapy in Small Cell Lung Cancer
Sponsor:
Astex Pharmaceuticals, Inc.
Organization: